Holocene Advisors
OCDX

Holocene Advisors’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Holocene Advisors’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-48,868
Closed -$912K – 1071
2022
Q1 		$912K Buy
+48,868
New +$879K ﹤0.01% 707

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Holocene Advisors's OCDX Position: Q2 2022 in Review

Holocene Advisors sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 48,868 shares — an estimated $912K sold.

Holocene Advisors first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $912K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Holocene Advisors reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Holocene Advisors sold 48,868 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $912K.
  • Holocene Advisors first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Holocene Advisors's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $912K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Holocene Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.